Articles about Zydus Cadila
Zydus Cadila is a multinational pharmaceutical company based in Ahmedabad, Gujarat. The company is also known as Cadila Healthcare Limited and is primarily engaged in the manufacturing of generic drugs. In 2020, it ranked 100 on the Fortune India 500 list. Cadila was founded in 1952 by Ramanbhai B. Patel (late) and his business partner Indravadan Modi. In 1995, the Patel and Mody families split and the latter's share was moved into a new company called Cadila Pharmaceuticals Limited. Cadila Healthcare remained the Patel family’s holding. It made its initial public offering on the Bombay Stock Exchange in 2000. In the fiscal year 2021, Cadila healthcare generated total revenue of ₹15,139 crores, of which the company's net income was ₹2,133 crores. As of 2021, Zydus Cadila employs 25,000 people. This is a stellar growth for Zydus Cadila that had a turnover of ₹250 crores in 1995 when the families split.
04 Oct 2021
Zydus Cadila's vaccine rollout likely in two weeks: Report
The indigenous COVID-19 vaccine developed by Zydus Cadila, called ZyCoV-D, is likely to be rolled out in the next two weeks.
02 Oct 2021
Here are some key drugs being tested for COVID-19 treatment
Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.
25 Aug 2021
NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive
The National Technical Advisory Group on Immunization (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's COVID-19 vaccine in the inoculation drive and prioritizing beneficiaries focusing on those aged 12-18 years with comorbidities.
22 Aug 2021
COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD
After receiving emergency use approval for its COVID-19 vaccine, Zydus Cadila will now submit an application to start vaccine trials for children aged 3-12 years, Managing Director Dr. Sharvil Patel said Saturday.
21 Aug 2021
Zydus Cadila's COVID-19 vaccine approved. What you need to know
Zydus Cadila's three-dose coronavirus vaccine has received the emergency use authorization from India's top drug regulator, becoming the sixth jab to get the nod in the country.
20 Aug 2021
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.
18 Aug 2021
COVID-19 vaccine for children likely by September, says ICMR-NIV chief
India will likely have a COVID-19 vaccine for children by next month, Dr. Priya Abraham said in an interview.
10 Aug 2021
Zydus Cadila COVID-19 vaccine may get emergency nod this week
India's second indigenous COVID-19 vaccine, developed by Zydus Cadila, is reportedly likely to get emergency use approval (EUA) this week.
24 Jul 2021
COVID-19 vaccines for children likely by September, says AIIMS chief
India will likely have its first coronavirus vaccine for children by September, said Dr. Randeep Guleria, the chief of Delhi's All India Institute of Medical Sciences (AIIMS).
09 Jul 2021
Zydus vaccine for 12-18-year-olds from September, says expert panel chief
Coronavirus vaccination for children with the Zydus Cadila vaccine will start by September, said Dr. NK Arora, the chief of National Expert Group on Vaccine Administration.
01 Jul 2021
Zydus applies for approval of its 3-dose, needle-free COVID-19 vaccine
Zydus Cadila, the Gujarat-based drug firm, has applied for the Emergency Use Authorization (EUA) of its COVID-19 vaccine to the Drugs Controller General of India (DCGI), the company said today.
19 Jun 2021
Zydus to seek approval for its COVID-19 vaccine next week
Zydus Cadila, the Gujarat-based drug firm, will next week apply for the emergency use authorization (EUA) of its COVID-19 vaccine in India, company sources told the media, adding it has apprised the government of its intention.
27 May 2021
Zydus seeks human trial approval for its COVID-19 antibody cocktail
Indian pharmaceutical firm Zydus Cadila has sought permission from the Drugs Controller General of India (DCGI) to conduct human clinical trials of its antibody cocktail meant to treat mild COVID-19 patients.
23 Apr 2021
Zydus Cadila's antiviral drug approved for treating moderate COVID-19 cases
The Drugs Controller General of India (DCGI) on Friday gave approval for the emergency use of Zydus Cadila's Hepatitis C drug "Virafin" for the treatment of moderate coronavirus infection in adults.
17 Dec 2020
India's neighbors train experts for clinical trials of COVID-19 vaccine
India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.
30 Nov 2020
Modi to chair all-party meet to review COVID-19 situation Friday
Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.
28 Nov 2020
Applying for Covishield's emergency approval in 2 weeks: SII
The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.
28 Nov 2020
Modi embarks on 3-city tour to view COVID-19 vaccine development
Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.
28 Nov 2020
PM to visit three cities to review coronavirus vaccine development
Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.
08 Nov 2020
Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
01 Nov 2020
Vaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
12 Oct 2020
COVAXIN to Oxford: Coronavirus vaccine updates for India
Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.
04 Oct 2020
Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government
The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.
22 Sep 2020
Vaccine expected by early 2021; nationwide immunization a challenge: Scientist
A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.
04 Sep 2020
#VaccineTracker: Early COVID-19 vaccine results expected by September 15
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
18 Aug 2020
Indian government starts talks to procure COVID-19 vaccine: Details here
Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.
15 Aug 2020
Three indigenous coronavirus vaccines in trials, distribution plan ready: PM
With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.
13 Aug 2020
Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India
In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.
07 Aug 2020
Israel claims to have 'excellent' COVID-19 vaccine in hand
Israel says it has an 'excellent' vaccine in hand to prevent COVID-19, the novel coronavirus disease.
06 Aug 2020
NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more
In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.
05 Aug 2020
Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial
Indian drug company Zydus Cadila has completed early-stage human trials with its indigenously developed COVID-19 vaccine.
05 Aug 2020
NewsBytes Briefing: Apple refreshes iMac, ex-Google exec gets prison term
In the updates since last night, Apple unveiled a refreshed 27-inch iMac.
25 Jul 2020
As coronavirus cases surge, PM to meet CMs next week
Prime Minister Narendra Modi is likely to convene a virtual meeting with Chief Ministers of all states on July 27, Monday, to discuss the coronavirus situation in their respective regions and the steps taken to mitigate the effect of the biggest health crisis in a century.
17 Jul 2020
India's COVID-19 vaccines: What are the latest updates?
In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.
09 Jul 2020
All you need to know about India's COVID-19 vaccines
As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.
05 Jul 2020
COVID-19 vaccine: What are the latest updates?
With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.
03 Jul 2020
India's second COVID-19 vaccine cleared for human trials: Details here
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
24 Jun 2020
These drugs are in use for COVID-19 treatment in India
India has opened up, but the pandemic is not slowing down.
11 May 2020
COVID KAVACH ELISA: First Indian antibody detection kit for coronavirus
In a major step forward, the Indian Council of Medical Research and National Institute of Virology have jointly announced the development of COVID KAVACH ELISA, the first indigenous antibody detection kit for COVID-19.
26 Sep 2019
GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance
Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.
